Importantly, despite the CD137 staining only minimally improving the detection of tumor-specific reactive CD4+ TILs, the assay effectively detected both CD8+ and CD4+ tumor-reactive TILs simultaneously. The gene discussed is TNFRSF9; the disease is neoplasm.